Debasish Tripathy

Capecitabine versus classical cyclophosphamide, methotrexate, and fluorouracil as first-line chemotherapy for advanced breast cancer

D. Tripathy, C. Bertelsen, Debasish Tripathy, 2012 .

Image-detected breast cancer: state of the art diagnosis and treatment.

Roland Holland, Henry M Kuerer, H. Kuerer, 2005, Journal of the American College of Surgeons.

MRI Phenotype Is Associated With Response to Doxorubicin and Cyclophosphamide Neoadjuvant Chemotherapy in Stage III Breast Cancer

Ying Lu, Laura Esserman, Nola Hylton, 2001, Annals of Surgical Oncology.

Pathologic complete response predicts recurrence-free survival more effectively by cancer subset: results from the I-SPY 1 TRIAL--CALGB 150007/150012, ACRIN 6657.

Nola Hylton, Carolyn Mies, Olufunmilayo I Olopade, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

HER-2 gene amplification can be acquired as breast cancer progresses.

Tanja Fehm, Sanjay Shete, Leon W M M Terstappen, 2004, Proceedings of the National Academy of Sciences of the United States of America.

Adaptive Randomization of Veliparib-Carboplatin Treatment in Breast Cancer.

Anne M Wallace, Michael Hogarth, Lajos Pusztai, 2016, The New England journal of medicine.

Adaptive Randomization of Neratinib in Early Breast Cancer.

Michael Hogarth, Lajos Pusztai, Rita Nanda, 2016, The New England journal of medicine.

Circulating Tumor Cells in Patients with Breast Cancer Dormancy

Tanja Fehm, Jonathan W. Uhr, Sanjay Shete, 2004, Clinical Cancer Research.

The Neoadjuvant Model Is Still the Future for Drug Development in Breast Cancer

Anne Wallace, Emanuel F Petricoin, Rita Nanda, 2015, Clinical Cancer Research.